Webinar

Virtual 21st Annual Pharmaceutical and Medical Device Compliance Congress: Mini Summit XXV

Friday, November 06 10:00 AM EDT to 11:00 AM EDT

PCF’s annual International Pharmaceutical Compliance Congress is one of the premier events for compliance and legal professionals in the bio/pharma industry worldwide. This year, Life Sciences Consulting Group Director Laura Skinner, will  participate on a panel focusing on reflections on successful co-promotion partnerships.

Mini Summit XXV: Reflections on a Successful Co-Promotion Partnership

Co-Promotions continue to be a hot and enticing strategic business option for drug and device makers, big and small. The attraction of co-promotes has intensified with the proliferation of specialty products and markets as manufacturers seek ways to maximize their resources and optimize selling and marketing efforts. Since co-promotes involve more than one organization, the associated compliance risks are intense and require a great deal of thought and coordination—more so compared to a unilateral commercial initiative. This experienced expert panel will share personal experiences with co-promotes, draw on insights, and provide the latest updates. Attend this session to learn from a cross functional group consisting of Pharma and Medical Device outside counsel, an experienced life sciences consulting expert, and three Chief Compliance Officers from small, midsized, and large companies. This impressive panel has extensive first-hand experience in all aspects of company co-promotions.

Topics covered include:

• How to work with your partner

• Early considerations

• Examples of successes and areas for improvement

• How to handle “deal fever”

• Policies and procedures

• Conflicts

• And more

Speakers:

• Laura Skinner, MBA
  Director, Life Sciences Consulting Group Paul Hastings LLP, Austin TX

• Anisa Dhalla
  Global Chief Compliance Officer, UCB, Atlanta, GA

• Gregory S. Moss, LLB
  Executive Vice President, General Counsel and Corporate Secretary, Chief Compliance Officer, Kadmon Holdings, New York, NY

• Joe Zimmerman
  Vice President, Chief Compliance Officer & Privacy Officer, Ferring Pharmaceuticals, Parsippany, NJ

• Mark Gardner, MBA, JD
  Managing Attorney, Gardner Law, PLLC; Adjunct Professor, Drug & Device Law, Mitchell Hamline School of Law; Stillwater, MN (Moderator)

For more information and to register, click here  to visit the conference website.